тел. +38 (044) 483-12-82

№6(8) 2025

Укр

DOI 10.37219/2528-8253-2025-6-21

Pukhlik SM, Titarenko OV
THE INFLUENCE OF THE COCHLEATON® ON THE PSYCHO-EMOTIONAL STATE OF PATIENTS WITH CHRONIC SENSORINEURAL HEARING LOSS
Pukhlik Sergey M
Odessa National Medical University
Head of the Department of Otorhinolaryngology
Doctor of Medical Sciences, Professor
E-mail: lor@te.net.ua
Orchid ID: http://orcid.org/0000-0001-7196-9642
Scopus Author ID: 6506298353
Titarenko Olga V
Odessa National Medical University
Department of Otorhinolaryngology
Associate Professor
Candidate of Medical Sciences
e-mail: otit3333@gmail.com
ORCID ID: https://orcid.org/0000-0002-6024-0757

Abstract

Purpose of the study: Study of everyday limitations in sound perception in people suffering from bilateral chronic sensorineural hearing loss, the resulting deficiencies in daily life and emotional background, and changes in the psychoemotional state of patients while taking the drug Cohleaton® for a month.

Materials and methods: To assess the auditory function of patients with chronic sensorineural hearing loss, we identified three general areas, namely, patient complaints associated with impaired functional abilities of the inner ear, speech intelligibility, spatial and emotional characteristics of the perception of the new quality of hearing. All patients were divided into 2 groups: the first – with 1-2 degrees of hearing loss, the second – with 3-4 degrees of hearing loss. The change in quantitative signs of anxiety and depression was assessed at the beginning and after the end of the full course of therapy.

Results: In the studied patients, a high level of correlation was found between the degree of hearing changes, the level of development of anxiety and depressive state. According to the data of the hospital scale of anxiety and depression, we obtained a significant improvement of both indicators, both in the individuals of group 1 practically to the normal level, and in the second group of patients – to the level of moderate degree, which indicates the restoration of social adaptation of patients with hearing impairment.

Conclusions: After the treatment, a decrease in anxiety and depression levels, an improvement in the psychological background of patients suffering from chronic sensorineural hearing loss were noted. Almost 75% of patients who used Cochleaton® noted a subjective improvement in their general condition, normalization of sleep, memory, a decrease in depression and restoration of the emotional background of everyday life, improving hearing by reducing tinnitus, as evidenced by a significant difference between the indicators before and after treatment.

Key words: sensorineural hearing loss, psychoemotional disorders, Cochleaton®.

Download.PDF

References

  1. Ogorenko VV, Yurieva LM, Nikolenko AE, Nosov SG, Shusterman TY, Likholetov EO, et al. [Psychological and psychiatric consequences of wartime: a textbook]. Dnipro: LIRA; 2023. 312 p. [In Ukrainian].
  2. Mc Garrigle R, Munro KJ, Dawes P, Stewart AJ, Moore DR, Barry JG, Amitay S. Listening effort and fatigue: what exactly are we measuring? A British Society of Audiology Cognition in Hearing Special Interest Group ‘white paper’. Int J Audiol. 2014 Jul;53(7):433-40. doi: 10.3109/14992027.2014.890296.
  3. Koumpa FS, Forde CT, Manjaly JG. Sudden irreversible hearing loss post COVID-19. BMJ Case Rep. 2020 Oct 13;13(11):e238419. doi: 10.1136/bcr-2020-238419.
  4. Titarenko OV, Dobronravova IV, Titarenko OA, Lisovetska VS. [Peculiarities of auditory analyzer damage in emigrants during martial law]. World of scientific research. Issue 24. Materials of the scientific and practical international conference; October 20-21, 2023; Ternopil-Opole, Ukraine-Poland. Ternopil; 2023. pp. 330-2. [In Ukrainian].
  5. Mustafa MWM. Audiological profile of asymptomatic Covid-19 PCR-positive cases. Am J Otolaryngol. 2020 May-Jun;41(3):102483. doi: 10.1016/j.amjoto.2020.102483.
  6. Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020 Jun:190:62. doi: 10.1016/j.thromres.2020.04.014.
  7. Maharani A, Pendleton N, Leroi I. Hearing Impairment, Loneliness, Social Isolation, and Cognitive Function: Longitudinal Analysis Using English Longitudinal Study on Ageing. Am J Geriatr Psychiatry. 2019 Dec;27(12):1348-1356. doi: 10.1016/j.jagp.2019.07.010.
  8. Noble W, Ter-Horst K, Byrne D. Disabilities and handicaps associated with impaired auditory localization. J Am Acad Audiol. 1995 Mar;6(2):129-40.
  9. Zabolotnyi DI, Shydlovska TA, Shydlovska TV, Petruk LG. [Diagnostics and principles of providing medical care to patients with sensorineural hearing impairments who received acute trauma during combat operations in the area of anti-terrorist operation]. Journal of the NAMSU. 2017;23(1-2):49-64.
  10. Pukhlik SM, Titarenko OV, Diedykova IV. Translation, adaptation and validation of the Ukrainian version of questionnaires for assessing the impact of hearing disorders on the psycho-emotional state of patients. Otorhinolaryngology. 2025;8(3-4):4-15. doi: 10.37219/2528-8253-2025-3-4-4. [Article in Ukrainian].
  11. Babienko VV, Mokienko OA, Polylyakh OA. Magnesium as an essential micronutrient: hygienic and medical-biological aspects: monograph. Odesa: Press-kurier; 2024. 300 p. ISBN 978-617-7797-50-9. [In Ukrainian].
  12. Libako P, Nowacki W, Rock E, Rayssiguier Y, Mazur А. Phagocyte priming by low magnesium status: input to the enhanced inflammatory and oxidative stress responses. Magnes Res. 2010 Mar; 23(1):1-4. doi: 10.1684/mrh.2009.0201.
  13. Marushko YV. [The role and place of magnesium deficiency in the development of vegetative-vascular dysfunction in children]. Zdorov’e rebenka. 2016;72(4):43-8. [Article in Ukrainian]. Available from: https://www.mif-ua.com/archive/article/43012.
  14. Sendowski І. Magnesium therapy in acoustic trauma, magnesium research. Magnes Res. 2006 Dec;19(4):244-54.
  15. Khaitovych MV. [The role of magnesium deficiency and its supplemation in diseases of central nervous system. Review]. Medical science of Ukraine. 2017;13(3-4):70-5. [Article in Ukrainian].
  16. Crimi E, Ignarro LJ, Napoli C. Microcirculation and oxidative stress. Free Radic Res. 2007 Dec; 41 (12):1364-75. doi: 10.1080/10715760701732830.
  17. Belcaro G, Cesarone MR, Scipione C, Scipione V, Cox D, Cornelli U, et al. Pycnogenol® improves cochlear-vestibular microcirculatory dysfunction, and associated symptoms. Otorhinolaryngology. 2024;74(1):18-22. doi: 10.23736/S2724-6302.23.02528-8.
  18. Hun N, Yuzhang C, Yi Z, Xiyue X. The relationship between serum homocysteine levels and sudden sensorineural hearing loss: a meta-analysis. Eur Arch Otorhinolaryngol. 2023 May;280(5): 2091-2097. doi: 10.1007/s00405-023-07829-w.
  19. Eikelboom JW, Lonn E, Genest JJr, Hankey G, Yusuf S. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999 Sep 7;131(5):363-75. doi: 10.7326/0003-4819-131-5-199909070-00008.
  20. Pishak VP, Kryvchanska MI, Riznichuk MO, Bulyk OR, Lukan YR. [Melatonin: biological role and optimization of its application]. Bukovinian Medical Herald. 2022; 26(2):86-90. doi: https://doi.org/10.24061/2413-0737.XXVI.2.102.2022.16. [Article in Ukrainian].
  21. Guerra J, Devesa J. Melatonin Exerts Anti-Inflammatory, Antioxidant, and Neuromodulatory Effects That Could Potentially Be Useful in the Treatment of Vertigo. Int J Otolaryngol. 2021 Mar 23:2021:6641055. doi: 10.1155/2021/6641055.
  22. Howland RH. Novel melatonin-based treatments for major depression. 2012 Jan 21;379(9812):215-6; author reply 217-9. doi: 10.1016/S0140-6736(12)60094-4.
  23. Borysenko OM, Poimanova OS, Serbin [Experience of using the Cochleaton® complex against the background of symptomatic treatment of patients with ear noise (tinnitus)]. Ukrainian medical journal. 2024;164(6):80-5. doi: 10.32471/umj.1680-3051.164.258919. [Article in Ukrainian].